Treat-to-Target Outcomes With Tapinarof Cream 1% in Phase 3 Trials for Plaque PsoriasisOctober 4, 2024Psoriasis
Need a Wood Lamp Alternative? Grab Your SmartphoneJune 10, 2024DermatopathologyPigmentation DisordersPsoriasisDiversity in Medicine
Depression As a Potential Contributing Factor in Hidradenitis Suppurativa and Associated Racial GapsMarch 5, 2024Psoriasis
A Cross-sectional Analysis of Regional Trends in Medicare Reimbursement for Phototherapy Services From 2010 to 2023February 1, 2024Psoriasis
Impact of Ketogenic and Low-Glycemic Diets on Inflammatory Skin ConditionsJanuary 30, 2024PsoriasisAcneAtopic DermatitisAutoimmune Diseases
Expanding the Psoriasis Framework: Immunopathogenesis and Treatment UpdatesJanuary 30, 2024PsoriasisPsoriatic Arthritis
Paradoxical Reaction to TNF-α Inhibitor Therapy in a Patient With Hidradenitis SuppurativaNovember 16, 2023PsoriasisAutoimmune Diseases
Potential Uses of Nonthermal Atmospheric Pressure Technology for Dermatologic Conditions in ChildrenOctober 30, 2023PediatricsPsoriasisWounds
Concurrent Atopic Dermatitis and Psoriasis Successfully Treated With Dual Biologic TherapySeptember 21, 2023Atopic DermatitisPsoriasis
Effect of COVID-19 Vaccination on Disease Severity in Patients With Stable Plaque Psoriasis: A Cross-sectional StudySeptember 5, 2023PsoriasisCOVID-19 Updates
